Autoimmune causes of encephalitis syndrome in Thailand: Prospective study of 103 patients

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Saraya, Abhinbhen ^a,b   Mahavihakanont, Aekkapol ^a,b   Shuangshoti, Shanop ^a,b   Sittidetboripat, Nuntaporn ^a,b   Deesudchit, Tayard ^a   Callahan, Michael ^c,d   Wacharapluesadee, Supaporn ^a,b   Wilde, Henry ^a,b   Hemachudha, Thiravat ^a,b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autoimmune encephalitis; Encephalitis; Limbic encephalitis; Paraneoplastic encephalitis

Indexed keywords

4 AMINOBUTYRIC ACID; AUTOANTIBODY; CA 125 ANTIGEN; CEPHALOSPORIN; CORTICOSTEROID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; AUTOIMMUNITY; BASAL CISTERN; BEHAVIOR CHANGE; BEHCET DISEASE; BRAIN ATROPHY; CEREBROSPINAL FLUID; CHILD; CLOSTRIDIUM TETANI; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CRANIAL NERVE PARALYSIS; DEMYELINATING DISEASE; DENGUE; DENGUE VIRUS; DISEASE COURSE; DROWSINESS; ENCEPHALITIS; ENCEPHALOMYELITIS; ENCEPHALOMYELORADICULITIS; ENTEROVIRUS INFECTION; EPSTEIN BARR VIRUS; FEMALE; FEVER; FUNGUS; HEADACHE; HEMIPARESIS; HERPES SIMPLEX VIRUS 1; HERPES VIRUS INFECTION; HUMAN; INFANT; INTRACTABLE EPILEPSY; JAPANESE ENCEPHALITIS VIRUS; LEUKOCYTE COUNT; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; MENINGOENCEPHALITIS; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; MYELITIS; MYELOOPTIC NEUROPATHY; MYELORADICULITIS; MYOKYMIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY TUMOR; PARANEOPLASTIC NEUROPATHY; PLASMAPHERESIS; PLEOCYTOSIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRODROMAL SYMPTOM; PROSPECTIVE STUDY; PROTEIN CEREBROSPINAL FLUID LEVEL; PSYCHOSIS; RADICULITIS; SCHOOL CHILD; SEIZURE; SEPSIS; SEPTICEMIA; STIFF MAN SYNDROME; THAILAND; THORAX RADIOGRAPHY; VARICELLA ZOSTER VIRUS; VIRUS ENCEPHALITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS; FEMALE; HASHIMOTO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THAILAND; YOUNG ADULT;

EID: 84885510542     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-150     Document Type: Article

References (30)

1. Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010, 10:835-844. 10.1016/S1473-3099(10)70222-X, 20952256.
2. Fowler A, Stodberg T, Eriksson M, Wickstrom R. Childhood encephalitis in Sweden: etiology, clinical presentation and outcome. Eur J Paediatr Neurol 2008, 12:484-490. 10.1016/j.ejpn.2007.12.009, 18313340.
3. Glaser CA, Gilliam S, Schnurr D, Forghani B, Honarmand S, Khetsuriani N, Fischer M, Cossen CK, Anderson LJ. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis 2003, 36:731-742. 10.1086/367841, 12627357.
4. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004, 62:1177-1182. 10.1212/01.WNL.0000122648.19196.02, 15079019.
5. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004, 127:701-712.
6. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007, 61:25-36. 10.1002/ana.21050, 2430743, 17262855.
7. Gable MS, Gavali S, Radner A, Tilley DH, Lee B, Dyner L, Collins A, Dengel A, Dalmau J, Glaser CA. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009, 28:1421-1429. 10.1007/s10096-009-0799-0, 2773839, 19718525.
8. Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-d-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the california encephalitis project. Clin Infect Dis 2012, 54:899-904. 10.1093/cid/cir1038, 3297648, 22281844.
9. Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013, 12:157-165. 10.1016/S1474-4422(12)70310-1, 23290630.
10. Abdullah S, Lim S-Y, Goh KJ, Lum LC, Tan CT. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A series of ten cases from a university hospital in Malaysia. Neurol Asia 2011, 16:241-246.
11. Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, Puttisri P, Hoke CH. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 1989, 40:418-427.
12. Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W, Wandinger KP. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci 2010, 291:52-56. 10.1016/j.jns.2010.01.002, 20117794.
13. Yang YY, Yin GL, Darnell RB. The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc Natl Acad Sci USA 1998, 95:13254-13259. 10.1073/pnas.95.22.13254, 23773, 9789075.
14. Ueki K, Ramaswamy S, Billings SJ, Mohrenweiser HW, Louis DN. ANOVA, a putative astrocytic RNA-binding protein gene that maps to chromosome 19q13.3. Neurogenetics 1997, 1:31-36. 10.1007/s100480050005, 10735272.
15. McKeon A, Pittock SJ. Paraneoplastic encephalomyelopathies: pathology and mechanisms. Acta Neuropathol 2011, 122:381-400. 10.1007/s00401-011-0876-1, 21938556.
16. Didelot A, Honnorat J. Update on paraneoplastic neurological syndromes. Curr Opin Oncol 2009, 21:566-572. 10.1097/CCO.0b013e3283306647, 19620862.
17. Darnell RB. Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc Natl Acad Sci USA 1996, 93:4529-4536. 10.1073/pnas.93.10.4529, 39311, 8643438.
18. Corradi JP, Yang C, Darnell JC, Dalmau J, Darnell RB. A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues. J Neurosci 1997, 17:1406-1415.
19. Okano HJ, Park WY, Corradi JP, Darnell RB. The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Genes Dev 1999, 13:2087-2097. 10.1101/gad.13.16.2087, 316965, 10465786.
20. Storstein A, Krossnes BK, Vedeler CA. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies. Acta Neurol Scand 2009, 120:64-67. 10.1111/j.1600-0404.2008.01138.x, 19486326.
21. McKeon A, Tracy JA, Pittock SJ, Parisi JE, Klein CJ, Lennon VA. Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. Arch Neurol 2011, 68:1282-1289. 10.1001/archneurol.2011.128, 21670387.
22. Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, Friedman D, Skeen MB, Grisold W, Kimura A, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010, 9:67-76. 10.1016/S1474-4422(09)70324-2, 2824142, 19962348.
23. Huang ZJ. GABAB receptor isoforms caught in action at the scene. Neuron 2006, 50:521-524. 10.1016/j.neuron.2006.05.005, 16701201.
24. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 2010, 62:405-496. 10.1124/pr.109.002451, 2964903, 20716669.
25. Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, Mata S, Kremens D, Vitaliani R, Geschwind MD, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009, 65:424-434. 10.1002/ana.21589, 2677127, 19338055.
26. Ogawa Y, Oses-Prieto J, Kim MY, Horresh I, Peles E, Burlingame AL, Trimmer JS, Meijer D, Rasband MN. ADAM22, a Kv1 channel-interacting protein, recruits membrane-associated guanylate kinases to juxtaparanodes of myelinated axons. J Neurosci 2010, 30:1038-1048. 10.1523/JNEUROSCI.4661-09.2010, 2811262, 20089912.
27. Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 2008, 70:1883-1890. 10.1212/01.wnl.0000312275.04260.a0, 18474843.
28. Poliak S, Gollan L, Salomon D, Berglund EO, Ohara R, Ranscht B, Peles E. Localization of Caspr2 in myelinated nerves depends on axon-glia interactions and the generation of barriers along the axon. J Neurosci 2001, 21:7568-7575.
29. Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002, 125:1887-1895. 10.1093/brain/awf178, 12135978.
30. Sureka J, Jakkani RK. Clinico-radiological spectrum of bilateral temporal lobe hyperintensity: a retrospective review. Br J Radiol 2012, 85(1017):e782-e792. doi:10.1259/bjr/30039090. Epub 2012 Mar 14, 10.1259/bjr/30039090, 3487100, 22422381.